|
Cirrhosis without SBP (n=62) |
Cirrhosis with SBP (n=6) |
Peritoneal tuberculosis (n=16) |
Chronic heart failure (n=10) |
Nephrotic syndrome (n=4) |
Malignancy (n=2) |
Mean
TLC/mm3 |
21.7±8.6 |
2184±775 |
419±92 |
18.9±7.5 |
20.5±7.9 |
122±8.4 |
Neutrophils
% |
78.7±10 |
71.5±8.6 |
15.2±6 |
79.6±9.7 |
78.2±14 |
59±4.2 |
Lymphocytes% |
21.2±10 |
27.6±10 |
84.75±6 |
20.4±9 |
21.7±14 |
41±4.2 |
|
Cirrhosis without SBP (n=62) |
Cirrhosis with SBP (n=6) |
Peritoneal tuberculosis (n=16) |
Chronic heart failure (n=10) |
Nephrotic syndrome (n=4) |
Malignancy (n=2) |
Mean AFTP (gm/dl) |
1.87±0.7 |
0.93±0.1 |
3.15±0.33 |
1.64±0.66 |
2.6±0.14 |
2.7±0.14 |
SAAG (gm/dl) |
2.12±0.5 |
1.37±0.1 |
0.67±0.15 |
2±0.4 |
0.88±0.31 |
0.8±0.14 |
|
Portal
hypertension present (n=78) |
Normal
portal pressure (n=22) |
P
value |
Mean
AFTP (gm/dl) |
1.77±0.73 |
3±0.37 |
<0.001 |
Mean
SAAG (gm/dl) |
2.05±0.5 |
0.72±0.19 |
<0.001 |
|
Portal hypertension present(n=78) |
Normal portal pressure (n=22) |
AFTP<2.5
gm/dl |
55 |
1 |
AFTP>2.5gm/dl |
23 |
21 |
sensitivity |
70.51% |
|
specificity |
95.45% |
|
|
Portal
hypertension present (n=78) |
Normal
portal pressure (n=22) |
SAAG≥1.1 |
72 |
1 |
SAAG<1.1 |
6 |
21 |
sensitivity |
92.31% |
|
specificity |
95.45% |
Complications
in cases of Ascites |
Liver
cirrhosis without SBP (n=62) |
Liver
cirrhosis with SBP (n=6) |
P
value |
1)
Variceal bleeding |
6
(9.6%) |
2(33.3%) |
0.09 |
2)
Hepatorenal syndrome |
7(11.2%) |
2(33.3%) |
0.13 |
3)Hepatic
encephalopathy |
12(19.35%) |
3(50%) |
0.08 |
4)
Deaths |
12(19.35%) |
4(66.67%) |
0.01 |
Studies on Ascites |
Year of study |
Total cases (n) |
Etiology (%) |
||||
Liver cirrhosis |
Peritoneal tuberculosis |
CHF |
Nephrotic syndrome |
Malignancy related ascites |
|||
Khan F Y et al[6] |
2007 |
104 |
59.6 |
7.8 |
6.7 |
2.9 |
20 |
Adhikari P et al[10] |
2012 |
43 |
48.83 |
11.62 |
4.62 |
- |
- |
Beg M et al[11] |
2001 |
100 |
60 |
24 |
10 |
-- |
6 |
Present study |
2013 |
100 |
68 |
16 |
10 |
4 |
2 |
Etiologies of Ascites |
Mean ascitic fluid total protein (AFTP) (gm/dl) |
Mean serum ascitic albumin
gradient (SAAG) (gm/dl) |
||
Khan F Y et al (2007) [6] |
Present study (2013) |
Khan F Y et al (2007) [6] |
Present study (2013) |
|
Liver cirrhosis without SBP |
1.6±
1.44 |
1.87 ±0.73 |
2.9±
2.25 |
2.12± 0.51 |
Liver cirrhosis with SBP |
2.1±
2.16 |
0.93± 0.11 |
1.60±
0.17 |
1.37± 0.16 |
Peritoneal tuberculosis |
2.76±
0.40 |
3.15 ±0.33 |
0.56±
0.32 |
0.67± 0.15 |
Chronic heart failure |
1.2±
3.22 |
1.64± 0.66 |
2.8±
2.25 |
2.03± 0.42 |
Nephrotic syndrome |
2.5±
0.65 |
2.6± 0.14 |
0.7±
0.23 |
0.88 ±0.31 |
Malignancy related |
2.5±
0.65 |
2.7± 0.14 |
0.90±
0.75 |
0.8± 0.14 |
Study |
Year of study |
Total cases (n) |
Sensitivity of SAAG |
Sensitivity of AFTP |
Beg M et
al [11] |
2001 |
100 |
94.73% |
65.62% |
U. H.
Malabu et al [13] |
2006 |
90 |
96% |
73% |
Khan F Y et al [6] |
2007 |
104 |
98.02% |
83.54% |
Present
study |
2013 |
100 |
92.31% |
70.51% |